Analyse de l'application SIBIONICS GS3 pour le 10 août

Regulatory Information: The SIBIONICS GS3 Continuous Glucose Monitoring (CGM) system is a CE-marked medical device (CE Mark issued under EU MDR). This app is only intended for use with SIBIONICS GS3 CGM sensors, which are legally available in the following countries and regions only: - European Union: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden - United Kingdom - Switzerland, Norway, Serbia - Australia - Israel - Hong Kong SAR, Macao SAR - Singapore, Brunei, Maldives, Sri Lanka - Oman - Malaysia - Qatar This app and device are NOT FDA-cleared and are not intended for sale or use in the United States or in any other country not listed above. Disclaimer: Always consult your healthcare provider before making any treatment decisions. Do not use this app as a substitute for professional medical advice.